TABLE 1.
Genotype | Gender | TC | FC:TC | LCAT activity | Hematocrit | Spleen |
---|---|---|---|---|---|---|
mg/dl | % | % | mg/g | |||
WT | F | 73 ± 9 | 29 ± 2 | 47.4 ± 1.4 | 3.7 ± 0.3 | |
M | 94 ± 3 | 25 ± 1 | 257 ± 49 | 48.4 ± 1.1 | 3.1 ± 0.5 | |
WT/CETP | F | 68 ± 13 | 28 ± 2 | 47.0 ± 2.9 | 4.2 ± 0.6 | |
M | 83 ± 6 | 25 ± 1 | 224 ± 5 | 47.9 ± 0.9 | 3.0 ± 0.7 | |
HypomSR-BI | F | 130 ± 12a | 30 ± 1 | 47.6 ± 1.7 | 3.7 ± 0.3 | |
M | 156 ± 10a | 31 ± 1b | 177 ± 51 | 46.9 ± 2.1 | 3.1 ± 0.8 | |
HypomSR-BI/CETP | F | 100 ± 15a,c | 31 ± 2 | 49.0 ± 2.6 | 3.9 ± 0.6 | |
M | 111 ± 14c | 33 ± 2a | 233 ± 76 | 47.5 ± 2.2 | 3.1 ± 0.4 | |
HypomSR-BI KOliver | F | 176 ± 13a | 49 ± 5a | 45.5 ± 1.9 | 5.9 ± 0.7a | |
M | 182 ± 10a | 51 ± 3a | 112 ± 30a | 44.7 ± 2.2b | 5.4 ± 1.5a | |
HypomSR-BI KOliver/CETP | F | 110 ± 9a,c | 49 ± 5a | 46.8 ± 1.6 | 4.7 ± 0.4b,d | |
M | 117 ± 24b,c | 49 ± 4a | 230 ± 59d | 45.1 ± 2.1b | 3.8 ± 0.6c | |
SR-BI−/− | F | 147 ± 6a | 51 ± 3a | 43.1 ± 1.6b | 6.6 ± 0.6a | |
M | 137 ± 14a | 52 ± 6a | 106 ± 50b | 42.3 ± 1.9a | 5.9 ± 1.6a | |
SR-BI−/−/CETP | F | 107 ± 9a,c | 47 ± 3a | 43.5 ± 1.9b | 6.2 ± 0.7a | |
M | 94 ± 10c | 48 ± 1a | 265 ± 72d | 42.1 ± 1.6a | 4.5 ± 0.8b,d |
a p < 0.001, statistically different from values for control mice.
b p < 0.05, statistically different from values for control mice.
c p < 0.001, statistically different from values for corresponding non-CETP transgenic mice.
d p < 0.05, statistically different from values for corresponding non-CETP transgenic mice.